Flaherty Keith T. 4
4 · Kinnate Biopharma Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
Flaherty Keith T.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-12+25,000→ 25,000 totalExercise: $3.48Exp: 2033-06-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 12, 2023 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date.